Skip to main content
. 2006 Jun 24;3(4):459–467. doi: 10.1093/ecam/nel030

Figure 4.

Figure 4

Comparison of effects of oral administrations of TJ-41 and TJ-48 (100 mg kg−1 per day each) on influenza virus-specific IgA antibody titers in nasal washes of young (A) and early aged BALB/c mice (B) against secondary intranasal inoculation of influenza A/PR/8 HA vaccine (5 μg per mouse). Influenza virus-specific IgA antibody titers were measured for the nasal washes collected at Day 42 by ELISA.